MediWound Ltd.
MediWound Ltd. is listed today as Mediwound: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2022 | $17 M | Private placement after listing | $10 to $50 million | options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Mediwound, its revenue in fiscal 2025 came from these business segments: USA $11.78 million (69%), Rest of the world $2.06 million (12%), Spain $1.29 million (8%), Italy $1 million (6%), Germany $820,000 (5%).
Annual report (SEC XBRL) · Dec 2025
MediWound Ltd. had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Oct 2022).
SEC Form D (revenue range) · Oct 2022
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Oct 2022
Products and services#
No products or services of MediWound Ltd. are on record.
Investors#
No investor of MediWound Ltd. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Boaz Gur-Lavie | Executive officer | Oct 2022 |
| Ety R. Klinger | Executive officer | Oct 2022 |
| Lior R. Rosenberg | Executive officer | Oct 2022 |
| Ofer Gonen | Executive officer | Oct 2022 |
| Tzvi R. Palash | Executive officer | Oct 2022 |
| Yaron R. Meyer | Executive officer | Oct 2022 |
| Assaf R. Segal | Director | Oct 2022 |
| David R. Fox | Director | Oct 2022 |
| Ety R. Klinger | Director | Oct 2022 |
| Nachum (Homi) Shamir | Director | Oct 2022 |
| Nissim R. Mashiach | Director | Oct 2022 |
| Sharon R. Kochan | Director | Oct 2022 |
| Sharon R. Malka | Director | Oct 2022 |
| Stephen T. Wills | Director | Oct 2022 |
| Vickie R. Driver | Director | Oct 2022 |
Went public since 2014. Its SEC number is that of a company listed on a stock exchange.